Law channel feed

Sen­ate Fi­nance Com­mit­tee to re­view fed­er­al poli­cies on drug short­ages

Last year
FDA+

Har­vard schol­ars call to elim­i­nate or­phan drug ex­emp­tion in IRA to save Medicare more

Last year

House com­mit­tee probes FTC dis­clo­sure of con­fi­den­tial in­fo in re­view­ing Am­gen-Hori­zon deal

Last year

Lo­cal Vir­ginia gov­ern­ments add to in­sulin law­suits against Eli Lil­ly, No­vo Nordisk, Sanofi, oth­ers

Last year
Pharma

FDA to SCO­TUS: Set­ting the mifepri­s­tone reg­u­la­tions clock back to 2016 is 'un­jus­ti­fied'

Last year
FDA+

Ab­b­Vie sues five gener­ic com­pa­nies over po­ten­tial Rin­voq com­peti­tors

Last year
Pharma

US In­ter­na­tion­al Trade Com­mis­sion takes on Eli Lil­ly's tirzepatide case

Last year
Pharma

Dai­ichi's long feud with In­di­an bil­lion­aire broth­ers now in­volves law­suit seek­ing $131M dam­ages

Last year
Pharma

Texas at­tor­ney gen­er­al sues Pfiz­er, Tris Phar­ma over man­u­fac­tur­ing is­sues sur­round­ing AD­HD med

Last year
Pharma

Im­prop­er Or­ange Book list­ings harm com­pe­ti­tion, FTC says in am­i­cus brief to an­titrust suit

Last year
Pharma
FDA+

Eli Lil­ly wins pre­lim­i­nary in­junc­tion in Moun­jaro case in drug­mak­er­s' on­go­ing bat­tle with com­pound­ing phar­ma­cies, well­ness spas

Last year
Pharma
Marketing

Michi­gan to re­peal phar­ma in­dus­try's le­gal li­a­bil­i­ty shield from 1995

Last year
Pharma

As­traZeneca pre­pares to live with the IRA, shift­ing fo­cus of ar­gu­ments to or­phan drug changes

Last year
Pharma

ADF asks SCO­TUS not to take up mifepri­s­tone case as Dan­co, DOJ say ar­gu­ments don't hold up

Last year
Pharma
FDA+

French au­thor­i­ties in­ves­ti­gate Sanofi over mar­ket ma­nip­u­la­tion, mis­lead­ing fi­nan­cial com­mu­ni­ca­tions

Last year
Pharma

FTC chal­lenges more than 100 drug patents owned by Ab­b­Vie, As­traZeneca, Boehringer and sev­en oth­ers

Last year
FDA+

Court may ex­pand 340B drug dis­count pro­gram as CMS preps $9B for 1,700 hos­pi­tals

Last year
Pharma

Sen­ate Fi­nance Com­mit­tee seeks to ad­vance bi­par­ti­san PBM re­forms along­side oth­er health bills

Last year
FDA+

US ar­gues that As­traZeneca's IRA suit 'fares no bet­ter than the oth­er­s'

Last year
Pharma

Nos­trum agrees to $50M set­tle­ment with DOJ over al­le­ga­tions of un­der­pay­ing Med­ic­aid

Last year
Pharma

EMA chief tells Eu­ro­pean Par­lia­ment it's no longer in cri­sis mode on pan­dem­ic, ready to han­dle short­ages

Last year
FDA+

No­var­tis sues Take­da af­ter for­mer em­ploy­ee al­leged­ly shared trade se­crets

Last year
Pharma

In­di­v­ior agrees to pay out $385M to end years­long Sub­ox­one lit­i­ga­tion and ac­cu­sa­tions it pre­vent­ed gener­ic com­pe­ti­tion

Last year
Pharma

Ic­ahn law­suit calls for mil­lions in dam­ages, re­moval of Il­lu­mi­na board mem­bers

Last year
First page Previous page 14151617181920 Next page Last page
A service from the Financial Times